Upregulation of these two proteins was closely associated with an unfavorable prognosis in lung cancer patients, suggesting that the PRKCSH-IGF1R axis is important not only as a reference for prognostic markers in lung cancer but also as a critical target for overcoming tumor resistance against NK cell-mediated antitumor immunity. Here, IGF1R is linked to lung cancer.